LevelJump Healthcare Corp. Closes Financing for $825,000
LevelJump Healthcare Corp. Closes Financing for $825,000
Toronto, Ontario--(Newsfile Corp. - October 2, 2023) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the "Company"), a Canadian leader in B2B telehealth solutions, is very pleased to announce that, further to its news release of September 14, 2023, it has now completed and closed a non-brokered private placement financing.
安大略省多倫多--(Newsfile Corp.-2023年10月2日)-加拿大B2B遠端醫療解決方案領先企業LevelJump Healthcare Corp.(多倫多證券交易所股票代碼：JUMP)(場外交易市場代碼：JMPHF)(FSE：75J)(“LevelJump”或“公司”)非常高興地宣佈，繼2023年9月14日發佈新聞稿後，該公司現已完成並結束了一項非經紀私募融資。
In connection with the private placement, the Company has issued a total of 825,000 preferred share units for aggregate gross proceeds of $825,000 at a price of $1.00 per unit (a "Unit").
就是次定向增發，本公司共發行825,000股優先股，總收益為825,000美元，價格為每單位(“單位”)1.00美元。
Each unit consists of (i) one Common Share at an issue price of $0.10 and (ii) one Class A Series 1 Convertible Preferred Share at an issue price of $0.90 and at a conversion price of $0.20 per Common Share. Each Preferred Share is non-voting, redeemable and carries a cumulative annual dividend of 12% paid quarterly, along with an annual top-up dividend representing 25% of the portion of LevelJump's EBITDA that is above $2.0 million, on a pro-rata basis.
每個單位包括(I)一股普通股，發行價為0.10美元；(Ii)一股A類系列1可轉換優先股，發行價為0.90美元，轉換價格為每股普通股0.20美元。每股優先股無投票權，可贖回，按季度支付累計年度股息12%，以及按比例計算的年度儲值股息，相當於LevelJump超過200萬美元的EBITDA部分的25%。
Proceeds from the non-brokered private placement are intended to be used for completing the Alberta acquisition and working capital. The Company has paid a finder's fee of $45,500 to certain finders in conjunction with this placement. All securities issued pursuant to this financing will be subject to resale restrictions for a period of four months and one day from closing under applicable securities legislation.
非經紀私募所得款項將用於完成對艾伯塔省的收購和營運資金。該公司已就此次配售向某些發現者支付了45,500美元的發起人費用。根據適用的證券法規，根據此次融資發行的所有證券將在四個月零一天的期限內受到轉售限制。
About LevelJump Healthcare
LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its IHF's (Independent Healthcare Facilities). JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.
關於LevelJump Healthcare
LevelJump Healthcare Corp.(多倫多證券交易所股票代碼：JUMP)通過其遠端放射部門為客戶醫院和成像中心提供遠端醫療解決方案，並通過其IHF(獨立醫療設施)提供面對面的放射服務。JUMP主要專注於緊急和緊急患者的危重護理，在我們所服務的社區中建立完整的關係。
ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.
我謹代表華為的董事會
LEVELJUMP醫療保健公司。
Mitchell Geisler
Chief Executive Officer
米切爾·蓋斯勒
首席執行官
Caitlin-Robyn Densmore
Investor Relations Manager
Caitlin.Densmore@leveljumphealthcare.com
(437) 214-1568
凱特琳-羅賓·丹斯莫爾
投資者關係經理
郵箱：Caitlin.Densmore@Levjumphelthare.com
(437)214-1568
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
關於前瞻性資訊的警示聲明
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).
本新聞稿包含與公司業務計劃和公司行業前景相關的適用證券法所指的“前瞻性資訊”。儘管本公司認為，根據其高級管理人員和董事的經驗、當前狀況和預期未來發展以及其他被認為合適的因素，這些前瞻性資訊中反映的預期是合理的，但不應過度依賴這些預期，因為本公司不能保證這些預期將被證明是正確的。實際結果和發展可能與這些陳述中預期的大不相同。本新聞稿中的陳述是截至本新聞稿發佈之日作出的，公司不承擔任何責任對其進行更新或修改，以反映除適用證券法所要求的以外的新事件或新情況。本公司沒有義務對第三方對本公司、加拿大TelerRadiology Services，Inc.、其證券或其各自的財務或經營業績(如適用)所作的分析、預期或陳述發表評論。
Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
交易所及其監管服務提供商(該術語在交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.
所發行的證券尚未、也不會根據修訂後的《1933年美國證券法》(下稱《美國證券法》)或美國任何州證券法進行註冊，在未進行註冊或未獲得美國證券法和適用的美國州證券法的註冊要求豁免的情況下，不得在美國境內或向美國人、為美國個人或為美國人的利益進行發行或銷售。本新聞稿不構成在美國或其他任何司法管轄區出售證券的要約或購買證券的要約。
To view the source version of this press release, please visit
要查看本新聞稿的源版本，請訪問
譯文內容由第三人軟體翻譯。